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Abstract
Background: Studies on liver regeneration following partial hepatectomy (PH) have identified several microRNAs
(miRNAs) that show a regulated expression pattern. These studies involve major surgery to access the liver, which is
known to have intrinsic effects on hepatic gene expression and may also affect miRNA screening results. We
performed two-third PH or sham laparotomy (SL) in Wistar rats to investigate the effect of both procedures on
miRNA expression in liver tissue and corresponding plasma samples by microarray and qRT-PCR analyses. As control
groups, non-treated rats and rats undergoing anesthesia only were used.
Results: We found that 49 out of 323 miRNAs (15%) were significantly deregulated after PH in liver tissue 12 to
48 hours postoperatively (>20% change), while 45 miRNAs (14%) were deregulated following SL. Out of these
miRNAs, 10 miRNAs were similarly deregulated after PH and SL, while one miRNA showed opposite regulation. In
plasma, miRNA upregulation was observed for miR-133a and miR-133b following PH and SL, whereas miR-100 and
miR-466c were similarly downregulated following anesthesia and surgery.
Conclusions: We show that miRNAs are indeed regulated by sham laparotomy and anesthesia in rats. These
findings illustrate the critical need for finding appropriate control groups in experimental surgery.
Keywords: Hepatectomy, Liver regeneration, microRNA, Sham laparotomy, Surgical stress
Background
The liver is a remarkable organ, not only with respect to
its diverse functions, but also its unique regenerative cap-
acity. After surgical resection, the liver is capable of fully
restoring its lost mass by compensatory growth of the
remaining tissue [1,2]. Partial hepatectomy (PH) is a com-
mon treatment for primary and secondary malignancies of
the liver [3,4]; therefore, it is important to fully understand
the process of liver regeneration. It is already well known
that cytokines, growth factors, and the metabolic network
initiate and modulate liver regeneration, but the under-
lying mechanisms that govern this regulation are not com-
pletely understood [5]. As part of the posttranscriptional
regulatory network, the role of small, non-coding micro-
RNAs (miRNAs) during liver regeneration after PH has
recently been investigated. These studies have shown that
miRNAs are essential key players in the initiation, modula-
tion, and termination of liver regeneration [6-14].
PH is associated with major surgery to access the liver,
triggering intrinsic side effects, such as local tissue dam-
age, inflammation, and wound healing. Thus, sham sur-
gery control groups are essential to control for effects
caused by the surgical procedure, especially considering
that these procedures also modulate the global gene
expression of non-treated healthy livers [15-17]. For
example, Juskeviciute et al. performed cDNA micro-
arrays on the liver tissue of partially hepatectomized and
sham-operated rats and found 16 genes (e.g., Lzts2 and
Serpina10) to be significantly regulated by sham surgery
compared to non-treated liver tissue [15]. Dransfeld et al.
found that the expression of 16 out of 242 investigated
genes was affected during the period of 48 hours after a
sham operation, e.g. downregulation of the organic anion
transporting polypeptide (Oatp)2 and upregulation of
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protein, Oatp5, p47phox, and system A (ATA2)) were
even more affected by sham surgery than by PH. Thus,
when interpreting these studies, the effects of surgical pro-
cedures on hepatic and global gene expression should be
carefully taken into account. Similar effects may lead to
false-positive or confounding results of miRNA screenings
after PH.
Based on these considerations, we investigated the effect
of sham surgery and anesthesia on microRNA expression
profiles in the liver. We analyzed miRNA expression pat-
terns in the liver of sham-operated rats and compared our
findings with miRNA analyses performed on liver tissue of
rats after 70% PH and after anesthesia only. Additionally,
we measured expression levels of specific miRNAs in the
plasma of these animals.
Methods
Animal studies
Sham laparotomy versus partial hepatectomy in Wistar rats
All experiments were performed after approval of the
Berlin institutional review board (license no. G 0154/09).
Male Wistar rats with an average weight of 320 g were
randomly divided into three groups (n=3 per group
a n dt i m ep o i n t ) .T h ef i r s tg r o u p( P H - g r o u p )u n d e r w e n t
70% partial hepatectomy according to Higgins and
Anderson [18] as previously described [6]. The animals
in the second group underwent sham surgery consisting
of anesthesia, medial ventral laparotomy, manual palpa-
tion of the liver, and analgesic medication (SL-group).
The total operation time for both groups was approxi-
mately 45 minutes. As controls, animals treated only
with anesthesia and analgesic medication (AN-group)
and non-treated animals were used.
The animals in the AN-group were treated with the
same anesthesia protocol used during PH and sham op-
erations. Briefly, animals were anesthetized for five mi-
nutes using 4.0 vol.% of isoflurane, and settled into an
anesthesia mask and treated with 2.5 vol.% for 30 mi-
nutes and 1.5 vol.% for another ten minutes. For peri-
operative pain treatment, the animals of the PH- and
SL-group received a single subcutaneous injection of
buprenorphine (Temgesic® 0.01 mg/kg body weight) thirty
minutes before the end of surgery, while the animals of
the AN-group received an injection of metamizole
(Novaminsulfon® 50 mg/kg body weight). Additionally,
all animals had free access to metamizole (50 mg/kg
b o d yw e i g h t )v i at h ed r i n k i n gw a t e r .
Animals in the PH-group and SL-group were sacrificed
12, 24, and 48 hours after the procedure, animals of the
AN-group were sacrificed after 24 hours, and non-treated
animals (used for normalization) were sacrificed immedi-
ately. Briefly, the aorta was punctured following 4.0 vol.%
isoflurane narcotization and blood samples were collected
in EDTA tubes. Subsequently, the portal vein was cannu-
lized, and the liver was flushed with ice-cold saline (total
anesthesia time: 7 minutes). Following liver explantation,
tissue samples were immediately snap frozen in liquid ni-
trogen. EDTA plasma was centrifuged at 1,500 × g for
15 min within 30 minutes after blood collection, and the
supernatant plasma was carefully removed and stored in
200 μla l i q u o t sa t−80°C until further analysis.
miRNA screening and validation
RNA purification from tissue and plasma samples
For RNA isolation, tissue samples with an average
weight of 20 mg were homogenized in 500 μl TRIzol
RNA Isolation Reagent (Invitrogen, Carlsbad, CA, USA).
Plasma samples (200 μl) were thawed on ice and centri-
fuged at 12,000 × g for 30 min at 4°C to concentrate
cell-free elements such as nucleotides in the lower part
of the tube. Next, the upper 150 μl of plasma were re-
moved from the sample and discarded. The remaining
50 μl of plasma were mixed with 500 μl TRIzol RNA
Isolation Reagent (1:10 volumes). RNA was isolated from
tissue specimens and plasma samples using the same
protocol. Briefly, samples were mixed with 100 μl
chloroform and centrifuged at 12,000 × g for 15 min at
4°C. The supernatant was collected and mixed with
500 μl isopropanol. After one hour of incubation, the
samples were centrifuged, and the isopropanol was care-
fully removed. After rinsing with 1 ml of 75% ethanol,
pellets were left to dry at 56°C and then dissolved in
20 μl DEPC-treated water. The RNA content and 260/
280 ratio were assessed using an Agilent 2100 Bioanaly-
zer (Agilent Technologies, Santa Clara, CA, USA).
miRNA microarray screening
The hybridization of individual liver samples (PH-group,
SL-group, and non-treated animals) was performed for
16 h at 42°C using the Geniom Biochip MPEA Rattus
norvegicus (Sanger miRBase version 14.0) from febit Inc.
with the Geniom RT®-Analyzer (febit, Heidelberg,
Germany) as previously described [6]. The microarray
data have been deposited in NCBI’s Gene Expression
Omnibus and are accessible through GEO Series acces-
sion number GSE23696
Quantitative real-time PCR analysis for miRNAs
All products were obtained from Applied Biosystems
(Foster City, CA). TaqMan MicroRNA Assays specific
for miR-100, miR-105, miR-133a, miR-133b and miR-
466c were used. U6 was chosen for normalization of tis-
sue miRNA expression whereas miR-451 was used for
normalization of plasma miRNA [19]. miRNA-specific
cDNA was synthesized from 100 ng of tissue-derived
miRNA or 1 μg of plasma-derived RNA using the Taq-
Man® MicroRNA Reverse Transcription Kit. PCR
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Master Mix II with UNG at 95°C for 10 minutes,
followed by 50 cycles of 95°C for 15 seconds and 60°C
for 1 minute in a PCR system (Applied Biosystems).
Analyses were performed using StepOnePlus™ (Applied
Biosystems) in triplicate for tissue miRNAs and in
quintuplicate for plasma miRNAs. Relative changes in




The miRNA expression in tissue and plasma samples
from animals in the PH-, SL-, or AN-groups was nor-
malized to non-treated animals. Statistical analyses
(Empirical Bayes Statistics) adjusted for multiple test-
ing, Student’s t-test, and one-way ANOVA with posthoc
multiple comparisons were performed using Biocon-
ductor open source software, Microsoft Excel for Mac
(V 14.1.4), and GraphPad Prism (Prism 4 for Macintosh
Version 4.0c (GraphPad Software, La Jolla, CA). All
data are expressed as mean±standard deviation (SD). A
p-value of less than 0.05 was considered statistically
significant.
Results
MicroRNA expression in the liver changes significantly
after partial hepatectomy and sham laparotomy in rats
Global miRNA microarray screening was performed on
a total of 323 miRNAs in rat liver samples at 12, 24, and
48 hours after PH or SL using the same tissue samples
and microarray data as in our previously published study
[6]. In the PH-group, 49 miRNAs were significantly
deregulated (e.g., rno-miR-26a/b, rno-miR-125b-5p and
various members of the let-7 family), showing an expres-
sion change to at least≤ 0.8 or ≥ 1.2 compared to normal
healthy liver [6], while 45 miRNAs showed significant
expression changes in liver samples of animals undergo-
ing SL (Table 1). Comparing significantly deregulated
miRNAs in the SL- and PH-group, we identified 10 miR-
NAs (rno-miR-100, rno-miR-105, rno-miR-1224, rno-
miR-133a/b, rno-miR-383, rno-miR-466c, rno-miR-483,
rno-miR-598-5p, and rno-miR-628) that showed similar
expression changes in both groups at the same postoper-
ative time point, while one miRNA (rno-miR-29a) was
regulated in the opposite direction at the same time point.
Additionally, 34 miRNAs were significantly deregulated
due to sham laparotomy but were unaffected following
PH (e.g., rno-miR-205, rno-miR-295, rno-miR-337 and
rno-miR-708). The five miRNAs that showed the strongest
expression changes from each group in Table 1 were in-
cluded for putative target analysis using the TargetScan rat
algorithm (www.targetscan.org; Release 6.2, June 2012).
Table 2 provides a selection of putative targets.
Influence of anesthesia on miRNA expression in the liver
We further examined the effect of inhalative isoflurane
anesthesia on the expression of the miRNAs that were
found to be equally deregulated following PH and SL.
Out of the 10 miRNAs found to be affected, we were
only able to investigate seven miRNAs since expression
levels for rno-miR-383, rno-miR-598-5p, and rno-miR-
628 were too low for qRT-PCR (CT cycles >40) in rat
liver tissue. Out of these miRNAs, two (rno-miR-100 and
rno-miR-466c) were significantly upregulated following
isoflurane anesthesia compared to untreated animals
(1.97 fold and 1.88 fold expression change, respectively;
p<0.01 and p=0.001). The other investigated miRNAs
showed no significant expression changes compared to
liver from non-treated animals (Figure 1).
Surgically induced miRNAs in plasma samples
Based on these findings, we investigated whether similar
miRNA expression differences were detectable in plasma
samples after PH, SL or anesthesia only. Out of the simi-
larily regulated miRNAs found in the microarray screen-
ing, only rno-miR-100, rno-miR-133a, rno-miR-133b,
and rno-miR-466c were reproducibly detected in all
investigated plasma samples. The expression levels of
rno-miR-100 and rno-miR-466c were similarly downreg-
ulated following PH, SL, and anesthesia only compared
to non-treated animals (Figure 2). Downregulation of
rno-miR-100 was statistically significant in the SL- and
AN-group, while rno-miR-466c downregulation was sig-
nificant in the PH- and SL-group. The expression of
both rno-miR-133a and rno-miR-133b was similarly
increased in plasma samples after PH and SL, with a 42-
fold (p= 0.04) and 24-fold change (p =0.01) for miR-
133a, respectively. The expression of both miRNAs was
not increased following anesthesia only. The investigated
miRNAs displayed no significant variation between the
PH- and SL- groups 24 hours after treatment.
Discussion
miRNAs are important regulators of posttranscriptional
gene expression, and there is a growing body of evidence
showing that miRNAs are involved in the regulation of
hepatocyte proliferation and liver regeneration [20]. As
PH is a common model to investigate miRNA expres-
sion changes during liver regeneration, it is important to
consider the side effects of the surgical procedure itself
in order to control for miRNAs that are deregulated but
not directly associated with liver regeneration. We found
a similar deregulation of 10 miRNAs in liver tissue fol-
lowing PH and SL. Only one miRNA (rno-miR-466c)
was similarly regulated in the anesthesia control group;
therefore the observed miRNA expression changes fol-
lowing PH and SL are most likely caused by the surgical
procedures and/or the subsequent (inflammatory) tissue
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miRNA FC (SL/control) FC (PH/control) Accession No.
12 h 24 h 48 h 12 h 24 h 48 h
A miRNAs similarly deregulated after partial hepatectomy and sham laparotomy
rno-miR-100 0.72* 0.92 0.86 0.69** 0.70** 0.88 MIMAT0000822
rno-miR-105 1.56* 1.50*** 1.49 ** 1.49 1.50*** 1.61* MIMAT0012825
rno-miR-133a 0.99 0.76* 0.70* 0.75 0.68** 0.80 MIMAT0000839
rno-miR-133b 0.82 0.68* 0.74 0.88 0.59** 0.84 MIMAT0003126
rno-miR-383 1.16 1.26* 1.25 1.25 1.29* 1.07 MIMAT0003114
rno-miR-466c 1.24 1.33** 1.03 1.36 1.53*** 1.28 MIMAT0005279
rno-miR-483 0.78* 0.82*** 0.73*** 0.60*** 0.70*** 0.56*** MIMAT0003121
rno-miR-598-5p 1.32 1.41** 1.32 1.46 1.40* 1.24 MIMAT0005324
rno-miR-628 1.29 1.37* 1.22 1.38* 1.31* 1.24 MIMAT0012836
rno-miR-1224 0.72 0.73*** 0.79 0.65* 0.69** 0.64* MIMAT0012827
B miRNAs with opposite regulation after partial hepatectomy and sham laparotomy
rno-miR-29a 1.05 1.24** 1.17 0.91 0.78*** 0.85 MIMAT0000802
C miRNAs with deregulation after sham laparotomy but not following partial hepatectomy
rno-miR-23b 0.97 1.21*** 1.16* 0.87 0.80* 0.86 MIMAT0000793
rno-miR-30b-5p 1.14 1.22** 1.17 0.88 0.88* 0.90 MIMAT0000806
rno-miR-31 1.16 1.21*** 1.24* 0.95 0.92 0.85 MIMAT0000810
rno-miR-92b 0.70* 0.75** 0.66*** 0.87 0.92 0.89 MIMAT0005340
rno-miR-129 0.81 0.86 0.77* 1.03 0.86 0.87 MIMAT0000600
rno-miR-143 1.27 1.32*** 1.38* 1.06 0.98 1.00 MIMAT0000849
rno-miR-151 1.13 1.21** 1.18* 0.91 0.93 0.91 MIMAT0000614
rno-miR-191 1.12 1.27*** 1.22* 0.98 0.96 1.04 MIMAT0000866
rno-miR-192 1.15 1.21** 1.18 0.94 0.87** 0.95 MIMAT0000867
rno-miR-194 1.17 1.22** 1.20 0.93 0.88** 0.96 MIMAT0000869
rno-miR-195 1.18 1.21*** 1.17* 0.95 0.87 0.92 MIMAT0000870
rno-miR-201 1.33* 1.30** 1.30* 1.31 1.18 1.11 MIMAT0012846
rno-miR-205 0.75 0.68** 0.76* 0.94 0.97 0.92 MIMAT0000878
rno-miR-224 1.12 1.28 1.46* 1.06 1.14 1.40 MIMAT0003119
rno-miR-295 0.82 0.67** 0.69* 0.99 0.91 0.89 MIMAT0012849
rno-miR-296 0.78 0.77* 0.76 0.84 0.86 0.89 MIMAT0004742
rno-miR-324-5p 0.77 0.76** 0.77* 0.91 0.89 0.92 MIMAT0000553
rno-miR-331 0.76 0.81 0.70* 0.79 0.71* 0.87 MIMAT0000570
rno-miR-337 1.12 1.42** 1.34 1.14 1.23 1.45 MIMAT0000577
rno-miR-343 0.70* 0.73* 0.68* 0.78 0.81 0.85 MIMAT0000591
rno-miR-365 0.66* 0.83* 0.76* 0.85 0.87 0.80 MIMAT0001549
rno-miR-425 1.14 1.21* 1.27* 1.14 1.05 1.12 MIMAT0005314
rno-miR-429 0.91 0.74** 0.81 0.95 0.91 0.81 MIMAT0001538
rno-miR-484 0.75* 0.66*** 0.61*** 0.89 0.81* 0.71 MIMAT0005319
rno-miR-511 0.94 1.32 1.47* 0.98 0.99 1.12 MIMAT0012829
rno-miR-532-5p 0.99 1.22* 1.22 1.05 0.98 1.05 MIMAT0005322
rno-miR-615 0.78 0.71* 0.87 0.93 0.92 0.96 MIMAT0012835
rno-miR-664 0.88 0.83 0.74* 0.81 0.73* 0.89 MIMAT0003382
rno-miR-667 0.81 0.85** 0.79** 0.84 0.83 0.84 MIMAT0012852
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in plasma samples. These findings highlight the critical
need for appropriate control groups in surgical miRNA
studies.
The most deregulated miRNAs (according to the strength
of expression changes considering the microarray data from
Table 1) are listed in Table 2. In order to identify pos-
sible molecular pathways in which these miRNAs are
implicated we provide TargetScan analysis data. The pu-
tative targets of the identified miRNAs include a lot
well-known regulators of hepatic growth, cell cycle con-
trol, and signal transduction, such as IGF1, SMAD4, IRS2,
and SP3, among others. The identification and molecular
confirmation of miRNA-mediated regulation of these
putative targets needs to be performed in future
investigations.
Sham operation controls are commonly performed in
the miRNA analyses of other organ systems [21-23]; how-
ever, this procedure is apparently not a standard proced-
ure in studies investigating miRNA expression changes
during liver regeneration. To date, eight comparable ex-
perimental miRNA studies using a rat PH model have
been published [6-10,24-26]. Surprisingly, in three of these
studies, sham operation controls were not performed at all
[24-26]. Kren et al. investigated the association of mRNAs
as well as miRNAs to free, membrane-, and cytoplasmic
polysomes 3, 6, and 24 hours following 70% partial hepa-
tectomy [24]. Their microarray data indicate that miRNA
associations to the polysome populations changed signifi-
cantly after PH (compared to non-resected liver) and they
suggest that these changes might be associated with the
Table 1 miRNAs differentially expressed in rat liver after PH and comparison with miRNA expression after SL (Continued)
rno-miR-668 0.80 0.73** 0.85 0.94 0.90 0.87 MIMAT0012839
rno-miR-708 1.55* 1.37* 1.47* 1.25 1.21 1.18 MIMAT0005331
rno-miR-760-3p 0.67* 0.81 0.81 1.08 1.05 0.87 MIMAT0005337
rno-miR-760-5p 0.78* 0.73*** 0.74** 0.89 0.84 0.88 MIMAT0005336
rno-miR-880 0.91 0.74* 0.94 0.87 0.81 0.78 MIMAT0005288
miRNAs listed in this table were significantly deregulated at the same time point after sham laparotomy or after partial hepatectomy in rat liver tissue (<0.8 fold
change or > 1.2 fold change compared to normal rat tissue; Empirical Bayes Statistics adjusted for multiple testing, each time point compared with 0 h; *p <0.05,
**p <0.01, ***p < 0.001). Boldface indicates miRNA deregulation at the same postoperative time point. Abbreviations: FC fold change, SL sham laparotomy, PH
partial hepatectomy.











1 rno-miR-105 1,61 N/A
2 rno-miR-466c 1,53 HLF, NFIB, HHIP
3 rno-miR-483 0,56 IGF1, SMAD4, DLC1
4 rno-miR-133b 0,59 SP3, MAP3K3,
FOXC1




after PH and SL





1 rno-miR-708 1,55 NRAS, KRAS, PPARA
2 rno-miR-511 1,47 N/A
3 rno-miR-224 1,46 SMAD4, SP7,
HOXD10
4 rno-miR-337 1,42 NLK, MET, CDK6
5 rno-miR-484 0,61 BCL2, IRS2, PHKB
The five miRNAs that showed the strongest expression changes from each group
in Table 1 were included for putative target analysis using the TargetScan rat
algorithm (www.targetscan.org; Release 6.2, June 2012). The table provides a
selection of putative targets. The ranking of microrna expression changes was
performed according to the microarray data from Table 1 considering significant
expression changes at all time points. For group A expression changes in the PH
but not the SL group were used (since these were considered more relevant to
the biological mechanisms of liver regeneration). PH – partial hepatectomy,
SL – sham laparotomy, N/A – not available.
Figure 1 miRNA expression in the liver of rats 24 hours after
isoflurane anesthesia. The effect of anesthesia on miRNA
expression in the liver was investigated by qRT-PCR using samples of
untreated animals vs. samples taken 24 hours following 45 minutes
of isoflurane anesthesia and pain medication. Relative miRNA expression
ratios (normal liver was considered to be 1) were normalized against
stably expressed U6 small nucleolar RNA (Student’s t-test, **p<0.01,
***p<0.001).
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sham operation controls, the possibility of some significant
changes that might have been caused by laparotomy alone
exists. Chen et al. performed small liver graft transplanta-
tions in male Lewis rats using 45%, 75%, and 95% of native
liver volume and 50% partial hepatectomy [25]. Although
a strict cut-off was chosen (upregulation of at least
200% and downregulation of at least 50%), microarray
expression changes were only applicable to native
controls. No sham operation was performed, which
may be a confounding factor regarding miRNA deregu-
lation found in their analyses. Zhang et al. used PH as a
traumatic liver injury model and analyzed circulating
miRNAs in the serum of operated rats to determine
specific biomarkers, but they also did not perform
sham operations [26]. They detected 21 overexpressed
miRNAs in serum 24 hours after PH. Two of these
miRNAs, miR-133a and miR-133b, were also found in
our analyses. Consistently, we observed a significant
upregulation of both miRNAs after PH and SL in
plasma samples. However, in our analyses the hepatic
tissue expression of both miRNAs was significantly re-
duced. Our findings, therefore, suggest that the upreg-
ulation of miR-133a/b in plasma samples might be a
consequence of surgical stress or trauma rather than
being specific to the hepatectomy. This notion is fur-
ther supported by the fact that miR-133a/b are highly
expressed in muscle tissue [27,28] and their increased
expression levels in the plasma might likely be the re-
sult of muscle trauma during and after laparotomy. In
general, the origin and function of extracellular miR-
NAs are still controversial. While circulating miRNAs
are likely to be by-products of cell apoptosis or tissue
injury [29], there is also evidence for active miRNA
transport to the extracellular space via exosomes, indicat-
ing either clearance or specific physiological functions [30].
In addition to the role of surgical stress, anesthesia
might also be a confounding factor in experimental sur-
gery causing independent miRNA expression changes.
Therefore, we performed anesthesia controls in our study,
and we identified miR-100 and miR-466c to be deregu-
lated in liver tissue and plasma samples of these animals.
While hepatic tissue miR-466c was consistently upregu-
lated after PH, SL, and AN, plasma miR-466c showed
lower expression levels only following PH and SL. Further-
more, tissue miR-100 was downregulated after PH and SL
but upregulated after AN, while plasma miR-100 was
lower expressed after SL and AN but not after PH.
These findings illustrate that plasma and tissue miRNA
expression levels do not necessarily have to correlate
(e.g. miRNA-466c) and that independent and differential,
even counteracting, effects of surgery and anesthesia might
a d du pt oav e r yc o m p l e xp i c t u re (e.g. tissue miRNA-100 is
downregulated by SL, which encompasses surgery and
anesthesia, but upregulated by AN alone). As isoflurane is
known to alter gene expression of liver, kidney, and heart
[31], and metamizole and buprenorphine interact with en-
zymes of the cytochrome P450 superfamily [32,33], it is
likely that perioperative procedures such as inhalative
anesthesia and pain medication may have a considerable ef-
fect on hepatic miRNA expression changes. It should be
noted at this point that different analgesic regimens were
used in the different groups in our study. Both the PH- and
t h eS L - g r o u pr e c e i v e db u p r e n o r p h i n e .H o w e v e r ,i nt h e
AN-group, buprenorphine was not given, since we ob-
served respiratory depression/apnea under this treatment
without major surgery. Therefore, the results of the AN-
group exclusively highlight the effects of isoflurane and
Figure 2 miRNA plasma levels in rats 24 hours after partial hepatectomy, sham operation, or isoflurane anesthesia. miRNA levels in
plasma samples of Wistar rats 24 hours after partial hepatectomy (PH), sham laparotomy (SL), or anesthesia only (AN). Measurements were
performed with qRT-PCR (n= 3). The results were normalized to untreated animals and are displayed in fold changes (miRNA levels in plasma
samples from untreated animals was considered to be 1; Student’s t-test, *p< 0.05, **p<0.01, ***p<0.001). Statistically significant differences
were not found 24 hours after the procedures between the PH- and SL-groups (Oneway anova, p> 0.05).
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Moreover, we did not monitor drinking water and metami-
zole consumption, which is a further potential confounder
of our results. As the animals did not have access to drug-
free drinking water, the relative level of ingestion of meta-
mizole should have been similar in all animals. However,
therapeutic drug monitoring (i.e. measurement of isoflur-
ane, buprenorphine, and metamizole blood levels) would
be the best choice to exclude any potential confounding ef-
fects of anesthetics or analgesics on the results of surgical
miRNA studies.
Another limitation of our study is its purely descriptive
nature. However, it was not our intention to investigate
the function of surgically induced miRNAs, but to
analyze factors confounding miRNA expression screen-
ings. It should be noted that we did not include female
rats and that other rat strains (e.g. Sprague–Dawley rats)
could show different results [34]. Furthermore, we can
only speculate on either the mechanisms causing the ob-
served miRNA deregulation or on its possible functional
implications. However, as we also found miRNA expres-
sion changes in mice kidneys at various time points after
sham laparotomy in a previous study [[35]; data not
shown], this effect might be neither species nor organ spe-
cific but represents a more general challenge for surgical
miRNA studies. Moreover, miRNA expression changes
following surgical interventions are not only limited to or-
gans or tissues but can also be detected in the circulation
(e.g. plasma). This should especially be considered when
designing interventional clinical studies using circulating
miRNAs as diagnostic biomarkers [36,37]. In both settings
the need to control for unspecific confounders is of out-
standing importance. However, it is naturally difficult to
use appropriate controls, such as sham operations, in a
clinical setting. Therefore, animal model studies require
even more sophisticated controls to allow for a more
meaningful translation into the clinical setting.
Conclusion
We show that miRNAs are significantly deregulated in
liver tissue due to sham operation and anesthesia only.
miRNA expression changes following surgical interven-
tions are not only limited to organs or tissues but can
also be detected in the circulation (e.g. plasma). As we
also observed miRNA expression changes in mice kid-
neys at various time points after sham laparotomy, this
effect might be neither species nor organ specific but
represents a more general challenge for surgical miRNA
studies. Therefore, we strongly emphasize to include ap-
propriate control groups in surgical miRNA studies so
as not to generate false-positive results.
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